Chronic Disease Focus of New Strategy 25/08/2022 Paul Adepoju Ministers and government officials took on noncommunicable diseases, sickle cell disease, health system reforms in response to the COVID-19 pandemic, and measures to fight tuberculosis among children in Africa during their meeting of the 72nd WHO Regional Committee for Africa this week. In an effort to curb Africa’s chronic disease crisis, African health ministers adopted […] Continue reading -> NEJM Study: Pfizer’s Paxlovid Reduces COVID-19 Death by 81% in Older Adults, Not Effective in Younger Patients 24/08/2022 Maayan Hoffman Pfizer’s COVID-19 oral antiviral Paxlovid was found to reduce the mortality rate among people over the age of 65 by 81% in a new Israeli study published Wednesday in the New England Journal of Medicine. However, the study also found no significant benefit of the drug in patients aged 64 and younger. It is the […] Continue reading -> Pfizer Submits Reguest to US FDA for Approval of Omicron-targeted COVID Booster Shot 23/08/2022 Zachary Brennan, via Endpoints News The Omicron-targeted boosters are coming. Almost 250 days since Omicron became the dominant variant in the US, Pfizer and BioNTech on Monday officially announced that they’ve requested an Emergency Use Authorization (EUA) from the US Food and Drug Administration for their booster dose of an Omicron BA.4/BA.5-adapted bivalent vaccine for those 12 and older. The […] Continue reading -> WHO Warns of New Ebola Threat in DRC 23/08/2022 John Heilprin A new case of Ebola has been confirmed in the Democratic Republic of the Congo’s eastern province of North Kivu, prompting health authorities to declare a resurgence of the deadly virus, World Health Organization (WHO) officials said on Tuesday. WHO announced that health authorities confirmed a 46-year-old woman died of the disease on 15 August […] Continue reading -> WHO Advocates Prevention Focus in Africa 23/08/2022 Paul Adepoju & John Heilprin African nations need to pivot to prevention in their fight against disease by “addressing its root causes” through a greater focus on improved diets, healthier environments, and better road safety, among other factors, WHO Director-General Dr Tedros Adhanom Ghebreyesus told the 72nd WHO Regional Committee for Africa meeting, at the opening of the weeklong session of […] Continue reading -> Monkeypox Vaccine: 62% of Recipients Experience No Side Effects, Says New Survey 22/08/2022 Maayan Hoffman A first-of-its-kind survey examining the side effects of the monkeypox vaccine in Israel found that the majority of recipients had no general symptoms. “Most of the side effects reported by the vaccinated are local and mild, which in most cases pass within one to three days,” said Miri Mizrahi Reuveni, Deputy CEO and Head of […] Continue reading -> Open Access 240 Compound Collection Launched in Fight Against Infectious and Mosquito-Borne Illnesses for World Mosquito Day 22/08/2022 Raisa Santos To mark World Mosquito Day, 20 August, the Global Health Priority Box has been launched to provide free access to 240 compounds to stimulate research into new drugs and insecticides. The initiative, launched by the Medicines for Malaria Venture (MMV) and the Innovative Vector Control Consortium (IVCC), provides scientists with starting points to advance the […] Continue reading -> WHO Recommends Two Monoclonal Antibodies for Ebola Treatment; Calls to Expand Access in Developing Countries 19/08/2022 John Heilprin In its first guidelines ever for Ebola treatment, the World Health Organization (WHO) advises using two monoclonal antibodies — mAb114 (Ansuvimab®, also known as Ebanga®) and REGN-EB3 (Inmazeb®) — that were first approved by the US Food and Drug Administration for use against the Zaire ebolavirus species in 2020. WHO says its “strong recommendations” for […] Continue reading -> How Can Social Innovation Improve Life in Rural Communities? 19/08/2022 Editorial team When Dr. Magaly Blas, an Associate Professor at the Universidad Peruana Cayetano Heredia in Peru, was researching the association between the human papillomavirus that causes cervical cancer and the human T-lymphotropic virus that causes leukaemia, she found herself travelling often to the Amazon region of Ucayali, home to an indigenous community among whom the disease […] Continue reading -> 2nd COVID Booster Advised For Highest Risk 18/08/2022 John Heilprin An expert panel of advisers to the World Health Organization (WHO) has recommended that countries consider a second COVID-19 booster dose for older, at-risk and immunocompromised people, echoing guidance provided by European and U.S. regulators months earlier. WHO’s Strategic Advisory Group of Experts (SAGE) on Immunization released its updated recommendations on Thursday, a week after […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
NEJM Study: Pfizer’s Paxlovid Reduces COVID-19 Death by 81% in Older Adults, Not Effective in Younger Patients 24/08/2022 Maayan Hoffman Pfizer’s COVID-19 oral antiviral Paxlovid was found to reduce the mortality rate among people over the age of 65 by 81% in a new Israeli study published Wednesday in the New England Journal of Medicine. However, the study also found no significant benefit of the drug in patients aged 64 and younger. It is the […] Continue reading -> Pfizer Submits Reguest to US FDA for Approval of Omicron-targeted COVID Booster Shot 23/08/2022 Zachary Brennan, via Endpoints News The Omicron-targeted boosters are coming. Almost 250 days since Omicron became the dominant variant in the US, Pfizer and BioNTech on Monday officially announced that they’ve requested an Emergency Use Authorization (EUA) from the US Food and Drug Administration for their booster dose of an Omicron BA.4/BA.5-adapted bivalent vaccine for those 12 and older. The […] Continue reading -> WHO Warns of New Ebola Threat in DRC 23/08/2022 John Heilprin A new case of Ebola has been confirmed in the Democratic Republic of the Congo’s eastern province of North Kivu, prompting health authorities to declare a resurgence of the deadly virus, World Health Organization (WHO) officials said on Tuesday. WHO announced that health authorities confirmed a 46-year-old woman died of the disease on 15 August […] Continue reading -> WHO Advocates Prevention Focus in Africa 23/08/2022 Paul Adepoju & John Heilprin African nations need to pivot to prevention in their fight against disease by “addressing its root causes” through a greater focus on improved diets, healthier environments, and better road safety, among other factors, WHO Director-General Dr Tedros Adhanom Ghebreyesus told the 72nd WHO Regional Committee for Africa meeting, at the opening of the weeklong session of […] Continue reading -> Monkeypox Vaccine: 62% of Recipients Experience No Side Effects, Says New Survey 22/08/2022 Maayan Hoffman A first-of-its-kind survey examining the side effects of the monkeypox vaccine in Israel found that the majority of recipients had no general symptoms. “Most of the side effects reported by the vaccinated are local and mild, which in most cases pass within one to three days,” said Miri Mizrahi Reuveni, Deputy CEO and Head of […] Continue reading -> Open Access 240 Compound Collection Launched in Fight Against Infectious and Mosquito-Borne Illnesses for World Mosquito Day 22/08/2022 Raisa Santos To mark World Mosquito Day, 20 August, the Global Health Priority Box has been launched to provide free access to 240 compounds to stimulate research into new drugs and insecticides. The initiative, launched by the Medicines for Malaria Venture (MMV) and the Innovative Vector Control Consortium (IVCC), provides scientists with starting points to advance the […] Continue reading -> WHO Recommends Two Monoclonal Antibodies for Ebola Treatment; Calls to Expand Access in Developing Countries 19/08/2022 John Heilprin In its first guidelines ever for Ebola treatment, the World Health Organization (WHO) advises using two monoclonal antibodies — mAb114 (Ansuvimab®, also known as Ebanga®) and REGN-EB3 (Inmazeb®) — that were first approved by the US Food and Drug Administration for use against the Zaire ebolavirus species in 2020. WHO says its “strong recommendations” for […] Continue reading -> How Can Social Innovation Improve Life in Rural Communities? 19/08/2022 Editorial team When Dr. Magaly Blas, an Associate Professor at the Universidad Peruana Cayetano Heredia in Peru, was researching the association between the human papillomavirus that causes cervical cancer and the human T-lymphotropic virus that causes leukaemia, she found herself travelling often to the Amazon region of Ucayali, home to an indigenous community among whom the disease […] Continue reading -> 2nd COVID Booster Advised For Highest Risk 18/08/2022 John Heilprin An expert panel of advisers to the World Health Organization (WHO) has recommended that countries consider a second COVID-19 booster dose for older, at-risk and immunocompromised people, echoing guidance provided by European and U.S. regulators months earlier. WHO’s Strategic Advisory Group of Experts (SAGE) on Immunization released its updated recommendations on Thursday, a week after […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pfizer Submits Reguest to US FDA for Approval of Omicron-targeted COVID Booster Shot 23/08/2022 Zachary Brennan, via Endpoints News The Omicron-targeted boosters are coming. Almost 250 days since Omicron became the dominant variant in the US, Pfizer and BioNTech on Monday officially announced that they’ve requested an Emergency Use Authorization (EUA) from the US Food and Drug Administration for their booster dose of an Omicron BA.4/BA.5-adapted bivalent vaccine for those 12 and older. The […] Continue reading -> WHO Warns of New Ebola Threat in DRC 23/08/2022 John Heilprin A new case of Ebola has been confirmed in the Democratic Republic of the Congo’s eastern province of North Kivu, prompting health authorities to declare a resurgence of the deadly virus, World Health Organization (WHO) officials said on Tuesday. WHO announced that health authorities confirmed a 46-year-old woman died of the disease on 15 August […] Continue reading -> WHO Advocates Prevention Focus in Africa 23/08/2022 Paul Adepoju & John Heilprin African nations need to pivot to prevention in their fight against disease by “addressing its root causes” through a greater focus on improved diets, healthier environments, and better road safety, among other factors, WHO Director-General Dr Tedros Adhanom Ghebreyesus told the 72nd WHO Regional Committee for Africa meeting, at the opening of the weeklong session of […] Continue reading -> Monkeypox Vaccine: 62% of Recipients Experience No Side Effects, Says New Survey 22/08/2022 Maayan Hoffman A first-of-its-kind survey examining the side effects of the monkeypox vaccine in Israel found that the majority of recipients had no general symptoms. “Most of the side effects reported by the vaccinated are local and mild, which in most cases pass within one to three days,” said Miri Mizrahi Reuveni, Deputy CEO and Head of […] Continue reading -> Open Access 240 Compound Collection Launched in Fight Against Infectious and Mosquito-Borne Illnesses for World Mosquito Day 22/08/2022 Raisa Santos To mark World Mosquito Day, 20 August, the Global Health Priority Box has been launched to provide free access to 240 compounds to stimulate research into new drugs and insecticides. The initiative, launched by the Medicines for Malaria Venture (MMV) and the Innovative Vector Control Consortium (IVCC), provides scientists with starting points to advance the […] Continue reading -> WHO Recommends Two Monoclonal Antibodies for Ebola Treatment; Calls to Expand Access in Developing Countries 19/08/2022 John Heilprin In its first guidelines ever for Ebola treatment, the World Health Organization (WHO) advises using two monoclonal antibodies — mAb114 (Ansuvimab®, also known as Ebanga®) and REGN-EB3 (Inmazeb®) — that were first approved by the US Food and Drug Administration for use against the Zaire ebolavirus species in 2020. WHO says its “strong recommendations” for […] Continue reading -> How Can Social Innovation Improve Life in Rural Communities? 19/08/2022 Editorial team When Dr. Magaly Blas, an Associate Professor at the Universidad Peruana Cayetano Heredia in Peru, was researching the association between the human papillomavirus that causes cervical cancer and the human T-lymphotropic virus that causes leukaemia, she found herself travelling often to the Amazon region of Ucayali, home to an indigenous community among whom the disease […] Continue reading -> 2nd COVID Booster Advised For Highest Risk 18/08/2022 John Heilprin An expert panel of advisers to the World Health Organization (WHO) has recommended that countries consider a second COVID-19 booster dose for older, at-risk and immunocompromised people, echoing guidance provided by European and U.S. regulators months earlier. WHO’s Strategic Advisory Group of Experts (SAGE) on Immunization released its updated recommendations on Thursday, a week after […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Warns of New Ebola Threat in DRC 23/08/2022 John Heilprin A new case of Ebola has been confirmed in the Democratic Republic of the Congo’s eastern province of North Kivu, prompting health authorities to declare a resurgence of the deadly virus, World Health Organization (WHO) officials said on Tuesday. WHO announced that health authorities confirmed a 46-year-old woman died of the disease on 15 August […] Continue reading -> WHO Advocates Prevention Focus in Africa 23/08/2022 Paul Adepoju & John Heilprin African nations need to pivot to prevention in their fight against disease by “addressing its root causes” through a greater focus on improved diets, healthier environments, and better road safety, among other factors, WHO Director-General Dr Tedros Adhanom Ghebreyesus told the 72nd WHO Regional Committee for Africa meeting, at the opening of the weeklong session of […] Continue reading -> Monkeypox Vaccine: 62% of Recipients Experience No Side Effects, Says New Survey 22/08/2022 Maayan Hoffman A first-of-its-kind survey examining the side effects of the monkeypox vaccine in Israel found that the majority of recipients had no general symptoms. “Most of the side effects reported by the vaccinated are local and mild, which in most cases pass within one to three days,” said Miri Mizrahi Reuveni, Deputy CEO and Head of […] Continue reading -> Open Access 240 Compound Collection Launched in Fight Against Infectious and Mosquito-Borne Illnesses for World Mosquito Day 22/08/2022 Raisa Santos To mark World Mosquito Day, 20 August, the Global Health Priority Box has been launched to provide free access to 240 compounds to stimulate research into new drugs and insecticides. The initiative, launched by the Medicines for Malaria Venture (MMV) and the Innovative Vector Control Consortium (IVCC), provides scientists with starting points to advance the […] Continue reading -> WHO Recommends Two Monoclonal Antibodies for Ebola Treatment; Calls to Expand Access in Developing Countries 19/08/2022 John Heilprin In its first guidelines ever for Ebola treatment, the World Health Organization (WHO) advises using two monoclonal antibodies — mAb114 (Ansuvimab®, also known as Ebanga®) and REGN-EB3 (Inmazeb®) — that were first approved by the US Food and Drug Administration for use against the Zaire ebolavirus species in 2020. WHO says its “strong recommendations” for […] Continue reading -> How Can Social Innovation Improve Life in Rural Communities? 19/08/2022 Editorial team When Dr. Magaly Blas, an Associate Professor at the Universidad Peruana Cayetano Heredia in Peru, was researching the association between the human papillomavirus that causes cervical cancer and the human T-lymphotropic virus that causes leukaemia, she found herself travelling often to the Amazon region of Ucayali, home to an indigenous community among whom the disease […] Continue reading -> 2nd COVID Booster Advised For Highest Risk 18/08/2022 John Heilprin An expert panel of advisers to the World Health Organization (WHO) has recommended that countries consider a second COVID-19 booster dose for older, at-risk and immunocompromised people, echoing guidance provided by European and U.S. regulators months earlier. WHO’s Strategic Advisory Group of Experts (SAGE) on Immunization released its updated recommendations on Thursday, a week after […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Advocates Prevention Focus in Africa 23/08/2022 Paul Adepoju & John Heilprin African nations need to pivot to prevention in their fight against disease by “addressing its root causes” through a greater focus on improved diets, healthier environments, and better road safety, among other factors, WHO Director-General Dr Tedros Adhanom Ghebreyesus told the 72nd WHO Regional Committee for Africa meeting, at the opening of the weeklong session of […] Continue reading -> Monkeypox Vaccine: 62% of Recipients Experience No Side Effects, Says New Survey 22/08/2022 Maayan Hoffman A first-of-its-kind survey examining the side effects of the monkeypox vaccine in Israel found that the majority of recipients had no general symptoms. “Most of the side effects reported by the vaccinated are local and mild, which in most cases pass within one to three days,” said Miri Mizrahi Reuveni, Deputy CEO and Head of […] Continue reading -> Open Access 240 Compound Collection Launched in Fight Against Infectious and Mosquito-Borne Illnesses for World Mosquito Day 22/08/2022 Raisa Santos To mark World Mosquito Day, 20 August, the Global Health Priority Box has been launched to provide free access to 240 compounds to stimulate research into new drugs and insecticides. The initiative, launched by the Medicines for Malaria Venture (MMV) and the Innovative Vector Control Consortium (IVCC), provides scientists with starting points to advance the […] Continue reading -> WHO Recommends Two Monoclonal Antibodies for Ebola Treatment; Calls to Expand Access in Developing Countries 19/08/2022 John Heilprin In its first guidelines ever for Ebola treatment, the World Health Organization (WHO) advises using two monoclonal antibodies — mAb114 (Ansuvimab®, also known as Ebanga®) and REGN-EB3 (Inmazeb®) — that were first approved by the US Food and Drug Administration for use against the Zaire ebolavirus species in 2020. WHO says its “strong recommendations” for […] Continue reading -> How Can Social Innovation Improve Life in Rural Communities? 19/08/2022 Editorial team When Dr. Magaly Blas, an Associate Professor at the Universidad Peruana Cayetano Heredia in Peru, was researching the association between the human papillomavirus that causes cervical cancer and the human T-lymphotropic virus that causes leukaemia, she found herself travelling often to the Amazon region of Ucayali, home to an indigenous community among whom the disease […] Continue reading -> 2nd COVID Booster Advised For Highest Risk 18/08/2022 John Heilprin An expert panel of advisers to the World Health Organization (WHO) has recommended that countries consider a second COVID-19 booster dose for older, at-risk and immunocompromised people, echoing guidance provided by European and U.S. regulators months earlier. WHO’s Strategic Advisory Group of Experts (SAGE) on Immunization released its updated recommendations on Thursday, a week after […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Monkeypox Vaccine: 62% of Recipients Experience No Side Effects, Says New Survey 22/08/2022 Maayan Hoffman A first-of-its-kind survey examining the side effects of the monkeypox vaccine in Israel found that the majority of recipients had no general symptoms. “Most of the side effects reported by the vaccinated are local and mild, which in most cases pass within one to three days,” said Miri Mizrahi Reuveni, Deputy CEO and Head of […] Continue reading -> Open Access 240 Compound Collection Launched in Fight Against Infectious and Mosquito-Borne Illnesses for World Mosquito Day 22/08/2022 Raisa Santos To mark World Mosquito Day, 20 August, the Global Health Priority Box has been launched to provide free access to 240 compounds to stimulate research into new drugs and insecticides. The initiative, launched by the Medicines for Malaria Venture (MMV) and the Innovative Vector Control Consortium (IVCC), provides scientists with starting points to advance the […] Continue reading -> WHO Recommends Two Monoclonal Antibodies for Ebola Treatment; Calls to Expand Access in Developing Countries 19/08/2022 John Heilprin In its first guidelines ever for Ebola treatment, the World Health Organization (WHO) advises using two monoclonal antibodies — mAb114 (Ansuvimab®, also known as Ebanga®) and REGN-EB3 (Inmazeb®) — that were first approved by the US Food and Drug Administration for use against the Zaire ebolavirus species in 2020. WHO says its “strong recommendations” for […] Continue reading -> How Can Social Innovation Improve Life in Rural Communities? 19/08/2022 Editorial team When Dr. Magaly Blas, an Associate Professor at the Universidad Peruana Cayetano Heredia in Peru, was researching the association between the human papillomavirus that causes cervical cancer and the human T-lymphotropic virus that causes leukaemia, she found herself travelling often to the Amazon region of Ucayali, home to an indigenous community among whom the disease […] Continue reading -> 2nd COVID Booster Advised For Highest Risk 18/08/2022 John Heilprin An expert panel of advisers to the World Health Organization (WHO) has recommended that countries consider a second COVID-19 booster dose for older, at-risk and immunocompromised people, echoing guidance provided by European and U.S. regulators months earlier. WHO’s Strategic Advisory Group of Experts (SAGE) on Immunization released its updated recommendations on Thursday, a week after […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Open Access 240 Compound Collection Launched in Fight Against Infectious and Mosquito-Borne Illnesses for World Mosquito Day 22/08/2022 Raisa Santos To mark World Mosquito Day, 20 August, the Global Health Priority Box has been launched to provide free access to 240 compounds to stimulate research into new drugs and insecticides. The initiative, launched by the Medicines for Malaria Venture (MMV) and the Innovative Vector Control Consortium (IVCC), provides scientists with starting points to advance the […] Continue reading -> WHO Recommends Two Monoclonal Antibodies for Ebola Treatment; Calls to Expand Access in Developing Countries 19/08/2022 John Heilprin In its first guidelines ever for Ebola treatment, the World Health Organization (WHO) advises using two monoclonal antibodies — mAb114 (Ansuvimab®, also known as Ebanga®) and REGN-EB3 (Inmazeb®) — that were first approved by the US Food and Drug Administration for use against the Zaire ebolavirus species in 2020. WHO says its “strong recommendations” for […] Continue reading -> How Can Social Innovation Improve Life in Rural Communities? 19/08/2022 Editorial team When Dr. Magaly Blas, an Associate Professor at the Universidad Peruana Cayetano Heredia in Peru, was researching the association between the human papillomavirus that causes cervical cancer and the human T-lymphotropic virus that causes leukaemia, she found herself travelling often to the Amazon region of Ucayali, home to an indigenous community among whom the disease […] Continue reading -> 2nd COVID Booster Advised For Highest Risk 18/08/2022 John Heilprin An expert panel of advisers to the World Health Organization (WHO) has recommended that countries consider a second COVID-19 booster dose for older, at-risk and immunocompromised people, echoing guidance provided by European and U.S. regulators months earlier. WHO’s Strategic Advisory Group of Experts (SAGE) on Immunization released its updated recommendations on Thursday, a week after […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Recommends Two Monoclonal Antibodies for Ebola Treatment; Calls to Expand Access in Developing Countries 19/08/2022 John Heilprin In its first guidelines ever for Ebola treatment, the World Health Organization (WHO) advises using two monoclonal antibodies — mAb114 (Ansuvimab®, also known as Ebanga®) and REGN-EB3 (Inmazeb®) — that were first approved by the US Food and Drug Administration for use against the Zaire ebolavirus species in 2020. WHO says its “strong recommendations” for […] Continue reading -> How Can Social Innovation Improve Life in Rural Communities? 19/08/2022 Editorial team When Dr. Magaly Blas, an Associate Professor at the Universidad Peruana Cayetano Heredia in Peru, was researching the association between the human papillomavirus that causes cervical cancer and the human T-lymphotropic virus that causes leukaemia, she found herself travelling often to the Amazon region of Ucayali, home to an indigenous community among whom the disease […] Continue reading -> 2nd COVID Booster Advised For Highest Risk 18/08/2022 John Heilprin An expert panel of advisers to the World Health Organization (WHO) has recommended that countries consider a second COVID-19 booster dose for older, at-risk and immunocompromised people, echoing guidance provided by European and U.S. regulators months earlier. WHO’s Strategic Advisory Group of Experts (SAGE) on Immunization released its updated recommendations on Thursday, a week after […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
How Can Social Innovation Improve Life in Rural Communities? 19/08/2022 Editorial team When Dr. Magaly Blas, an Associate Professor at the Universidad Peruana Cayetano Heredia in Peru, was researching the association between the human papillomavirus that causes cervical cancer and the human T-lymphotropic virus that causes leukaemia, she found herself travelling often to the Amazon region of Ucayali, home to an indigenous community among whom the disease […] Continue reading -> 2nd COVID Booster Advised For Highest Risk 18/08/2022 John Heilprin An expert panel of advisers to the World Health Organization (WHO) has recommended that countries consider a second COVID-19 booster dose for older, at-risk and immunocompromised people, echoing guidance provided by European and U.S. regulators months earlier. WHO’s Strategic Advisory Group of Experts (SAGE) on Immunization released its updated recommendations on Thursday, a week after […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
2nd COVID Booster Advised For Highest Risk 18/08/2022 John Heilprin An expert panel of advisers to the World Health Organization (WHO) has recommended that countries consider a second COVID-19 booster dose for older, at-risk and immunocompromised people, echoing guidance provided by European and U.S. regulators months earlier. WHO’s Strategic Advisory Group of Experts (SAGE) on Immunization released its updated recommendations on Thursday, a week after […] Continue reading -> Posts navigation Older postsNewer posts